Positive association between constipation and mild cognitive impairment in elders: A cross-sectional study

Kai-Yong Huang,Zhen-Zhen Yu,Jia-Jun Tu,Xian-Yan Tang,Jin-Meng Huang,Tian-Ming Lu,Yu-Qian Lu,Mei-Chun Huang,Jing Zhou,Andrea B. Maier,Kaisy Xinhong Ye,Zi Yang,Lei Feng,Guo-Dong Lu
DOI: https://doi.org/10.1097/md.0000000000039943
IF: 1.6
2024-10-09
Medicine
Abstract:With the acceleration of world's population aging, the number of people living with dementia is rapidly growing from 55 million in 2019 to 139 million in 2050 worldwide, according to the latest World Health Organization global status report. [ 1 ] Alzheimer disease (AD), the most common form of dementia, is a progressive neurodegenerative disease that causes memory and cognitive decline, accompanied by psychiatric symptoms and behavioral disorders. [ 2 ] So far, there is few clinically-approved effective drug to treat AD (e.g. donepezil, rivastigmine, galantamine, memantine, and memantine combined with donepezil). Mild cognitive impairment (MCI), as an intermediate stage of cognitive impairment between physiological cognitive aging and pathological dementia, does not significantly affect daily life. [ 3 , 4 ] A large number of population-based epidemiological investigations have reported that the prevalence of MCI ranged from 3% to 19% among people aged 65 and above. [ 4 , 5 ] Around 30% to 50% of older adults with MCI progress to dementia within 5 years, compared with 3% of those without MCI at the same age. [ 4–6 ] But some persons with MCI can remain stable or return to normal over time. That is why MCI can be regarded as a transition stage before the onset of dementia. However, it is yet to be validated whether MCI is a critical stage to prevent or delay the development of dementia by adopting the beneficial factors and/or controlling risk factors of MCI.
medicine, general & internal
What problem does this paper attempt to address?